Literature DB >> 16239541

Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model.

Sameera Sayeed1, M E Fernandez-Miyakawa, Derek J Fisher, Vicki Adams, Rachael Poon, Julian I Rood, Francisco A Uzal, Bruce A McClane.   

Abstract

Clostridium perfringens type D enterotoxemias have significant economic impact by causing rapid death of several domestic animal species. Consequently, domestic animals are commonly vaccinated, at varying efficacy, with inactivated type D vegetative supernatants. Improved type D vaccines might become possible if the lethal toxins produced by type D isolates were characterized and the contributions of those toxins to supernatant-induced lethality were established. Therefore, the current study evaluated the presence of lethal toxins in supernatants prepared from late-log-phase vegetative cultures of a large collection of genotype D isolates. Under this growth condition, most genotype D isolates produced variable levels of at least three different lethal toxins, including epsilon-toxin (ETX). To model the rapid lethality of type D enterotoxemias, studies were conducted involving intravenous (i.v.) injection of genotype D vegetative supernatants into mice, which were then observed for neurotoxic distress. Those experiments demonstrated a correlation between ETX (but not alpha-toxin or perfringolysin O) levels in late-log-phase genotype D supernatants and lethality. Consistent with the known proteolytic activation requirement for ETX toxicity, trypsin pretreatment was required for, or substantially increased, the lethality of nearly all of the tested genotype D vegetative supernatants. Finally, the lethality of these trypsin-pretreated genotype D supernatants could be completely neutralized by an ETX-specific monoclonal antibody but not by an alpha-toxin-specific monoclonal antibody. Collectively, these results indicate that, under the experimental conditions used in the present study, ETX is necessary for the lethal properties of most genotype D vegetative supernatants in the mouse i.v. injection model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239541      PMCID: PMC1273886          DOI: 10.1128/IAI.73.11.7413-7421.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Atypical cpb2 genes, encoding beta2-toxin in Clostridium perfringens isolates of nonporcine origin.

Authors:  B Helen Jost; Stephen J Billington; Hien T Trinh; Dawn M Bueschel; J Glenn Songer
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.

Authors:  A F Habeeb
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

3.  Production, purification, and assay of Clostridium perfringens enterotoxin.

Authors:  J L McDonel; B A McClane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Phenotypic characterization of enterotoxigenic Clostridium perfringens isolates from non-foodborne human gastrointestinal diseases.

Authors:  R E Collie; J F Kokai-Kun; B A McClane
Journal:  Anaerobe       Date:  1998-04       Impact factor: 3.331

Review 5.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

6.  Anti-idiotypic antibody-induced protection against Clostridium perfringens type D.

Authors:  D A Percival; A D Shuttleworth; E D Williamson; D C Kelly
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.

Authors:  M M Awad; D M Ellemor; R L Boyd; J J Emmins; J I Rood
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals.

Authors:  A Ginter; E D Williamson; F Dessy; P Coppe; H Bullifent; A Howells; R W Titball
Journal:  Microbiology (Reading)       Date:  1996-01       Impact factor: 2.777

9.  Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens.

Authors:  J F Kokai-Kun; J G Songer; J R Czeczulin; F Chen; B A McClane
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

10.  Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets.

Authors:  Michael Waters; Amanda Savoie; Helen S Garmory; Dawn Bueschel; Michel R Popoff; J Glenn Songer; Richard W Titball; Bruce A McClane; Mahfuzur R Sarker
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  37 in total

1.  Review of Restricted Experiment Requests, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 2006-2013.

Authors:  Jacinta Smith; Denise Gangadharan; Robbin Weyant
Journal:  Health Secur       Date:  2015-09-08

2.  Virulence plasmid diversity in Clostridium perfringens type D isolates.

Authors:  Sameera Sayeed; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

3.  Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.

Authors:  Meredith L Hughes; Rachael Poon; Vicki Adams; Sameera Sayeed; Juliann Saputo; Francisco A Uzal; Bruce A McClane; Julian I Rood
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

Review 4.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

5.  Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid.

Authors:  Kazuaki Miyamoto; Jihong Li; Sameera Sayeed; Shigeru Akimoto; Bruce A McClane
Journal:  J Bacteriol       Date:  2008-09-05       Impact factor: 3.490

Review 6.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 7.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

8.  Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

Authors:  J P Garcia; J Beingesser; O Bohorov; N Bohorova; C Goodman; D Kim; M Pauly; J Velasco; K Whaley; L Zeitlin; C J Roy; F A Uzal
Journal:  Toxicon       Date:  2014-06-17       Impact factor: 3.033

9.  Lethal effects of Clostridium perfringens epsilon toxin are potentiated by alpha and perfringolysin-O toxins in a mouse model.

Authors:  Mariano E Fernandez-Miyakawa; B Helen Jost; Stephen J Billington; Francisco A Uzal
Journal:  Vet Microbiol       Date:  2007-10-02       Impact factor: 3.293

10.  Organization of the cpe locus in CPE-positive clostridium perfringens type C and D isolates.

Authors:  Jihong Li; Kazuaki Miyamoto; Sameera Sayeed; Bruce A McClane
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.